Penicillium marneffei infection in patients infected with human immunodeficiency virus. NLM AIDSLINE Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Penicillium marneffei infection in patients infected with human immunodeficiency virus.

Curr Top Med Mycol. 1997 Dec;8(1-2):35-42. Unique Identifier : AIDSLINE MED/98164816
Vanittanakom N; Sirisanthana T; Faculty of Medicine, Chiang Mai University, Thailand.


Abstract: Opportunistic infections are major causes of morbidity in patients with human immunodeficiency virus (HIV) infection. Penicillium marneffei infection is very common in HIV-infected individuals in northern Thailand. The patients usually present with fever, anemia, weight loss, skin lesions, generalized lymphadenopathy, and hepatomegaly. The average number of CD4+ T-lymphocytes at presentation was 63.8 cells/mm3. Diagnosis depends on familiarity with the clinical syndromes and support from the mycology laboratory. The response to antifungal treatment of the patients is generally good, but depends on the ability of the physician to make the diagnosis and start the treatment early. New approaches to the laboratory diagnosis of P. marneffei infection have been reported. Further study of these approaches may help physicians in taking better care of the patients.
Keywords: *AIDS-Related Opportunistic Infections/EPIDEMIOLOGY *AIDS-Related Opportunistic Infections/MICROBIOLOGY *AIDS-Related Opportunistic Infections/THERAPY *Mycoses/DIAGNOSIS *Mycoses/EPIDEMIOLOGY *Mycoses/MICROBIOLOGY *Mycoses/PREVENTION & CONTROL *Mycoses/THERAPY *Penicillium/ISOLATION & PURIFKWDaids-relatedopportunisticinfections/epidemiologyKWDaids-relatedopportunisticinfections/microbiologyKWDaids-relatedopportunisticinfections/therapyKWDmycoses/diagnosisKWDmycoses/epidemiologyKWDmycoses/microbiologyKWDmycoses/prevention&controlKWDmycoses/therapyKWDpenicillium/isolation&purif
980630
M9861784

Copyright © 1998 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .